Navigation Links
Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
Date:4/23/2010

IRVINE, Calif., April 23 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) will announce results for the Company's fiscal third quarter of 2010 for the period ended March 31, 2010 on Thursday, April 29, 2010 after the market closes.

Following the release, Pro-Dex will conduct a conference call at 4:30 p.m. Eastern Time (1:30 Pacific Time) to discuss operating performance for the quarter.  Mark Murphy, Chief Executive Officer and Jeff Ritchey, Chief Financial Officer, plan to host the call.  If you would like to join the call, domestic callers dial (866) 317-6010 and international callers dial (412) 317-6010, conference I.D. 440155.  You can identify the call as the Pro-Dex Third Quarter Earnings Call.  The call will also be broadcast live over the internet and may be accessed directly by visiting www.videonewswire.com/event.asp?id=68584 or by visiting the Company's website at www.pro-dex.com.  

For those who cannot access the live broadcast, a replay will be available from 2 hours after the call for 48 hours by dialing (877) 344-7529 for domestic callers or (412) 317-0088 for international callers, and entering conference I.D. number 440155.  An online archive of the broadcast will be available on the Company's website www.pro-dex.com for 365 days.  

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate miniature rotary drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.

For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
2. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
3. PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement
4. pHase Pharmaceuticals Announces New Venture
5. Sagent Pharmaceuticals Announces U.S. FDA Tentative Approval of Additional Adenosine Injection, USP Vial Presentations
6. Dehaier Medical Systems Announces Closing of Initial Public Offering on NASDAQ
7. Renhuang Pharmaceuticals Announces Continual Improvement in Days Sales Outstanding
8. Codexis, Inc. Announces Pricing of Initial Public Offering
9. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
10. Portola Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of PRT062607, an Oral, Syk-Specific Inhibitor for Chronic Inflammatory Disease Indications
11. Garnet BioTherapeutics Announces First Patient Treated in Trial of New Therapy for Improvement in Scar Appearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... June 19, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), will ... webcast on Friday, July 28, 2017, beginning at 7:30 a.m. ... Only Dial-in information: To participate in the conference call, dial ... the call at least 10 minutes prior to the start ... Webcast: A simultaneous ...
(Date:6/16/2017)... , June 16, 2017 Datascope Corp. is voluntarily ... Datascope Corp. for a potential electrical test failure code.     ... PART NUMBER ... IABP CS300 IABP ... ...
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
Breaking Medicine Technology:
(Date:6/24/2017)... ... June 24, 2017 , ... ... genetic testing for medications in select Florida and Texas doctors' offices and clinics. ... This new application of genetic testing recognizes the role genes play in determining ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Military Officers Association of America ... secretary of Veterans Affairs, retired Marine Col. Thomas G. Bowman. , Bowman currently serves ... Bowman brings an intimacy with the issues and challenges veterans face with the VA. ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... The ... facelift . Dr. Talei has come up with a proprietary technique that he ... and lifts tissues that have dropped. For all ages, patients can expect to look ...
(Date:6/23/2017)... ... , ... PureLife Dental is pleased to announce that California Dental Association (CDA) ... of the amalgam separator endorsement, all CDA members may purchase an ECO II amalgam ... value. This partnership between PureLife and CDA is especially timely as it coincides with ...
Breaking Medicine News(10 mins):